- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02887339
Ethical, Legal, and Social Issues Substudy in Relation to the GTEx Project (ELSI)
Ethical, Legal, and Social Issues Substudy in Relation to the Genotype-Tissue Expression Project
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The Genotype Tissue Expression Project (GTEx) is a partnership between multiple NIH agencies and funded by the Common Fund. Families who agreed to donation of organs and tissues for transplantation were asked to authorize the collection of additional tissues for GTEx by participating Organ Procurement Organizations (OPO). Donated tissues are placed in a National Cancer Institute biobank, and the donor's genome and medical record information analyzed and released to researchers through NIH's database of Genotypes and Phenotypes (dbGaP). The tissues and information will be kept in the biobank indefinitely and cell lines may be developed from the donated skin and blood.
An ethical, legal and social issues (ELSI) sub-study examines the issues surrounding risks to privacy and breach of confidentiality to family decision makers (FDM) as well as FDM perspectives on the return of findings to donor families. The ELSI sub-study assessed the authorization process and make suggestions for its improvement. Semi-structured interviews were completed with families who decided to donate to GTEx as well as those who refused to donate to the project. Tissue requesters (TR) who make the GTEx approaches for participating OPOs, were also asked to complete an online survey for each approach they completed for GTEx.
The study builds on this research team's extensive work in organ and tissue donation and the work currently being conducting during the ELSI pilot of the GTEx project. Specifically, the investigators propose to examine the impact of stress and complex information on donor families' decision-making to inform the consent process; understand how variations in requesters, consent approaches, and the characteristics of family decision makers affect understanding, recall of and willingness to donate tissues for research; consider the ethical and legal issues of the request and consent process; and, test a novel intervention designed to train tissue requesters to employ effective communication techniques when making requests for tissue. The overall goal is to develop a set of recommendations that will maximize the likelihood that family decision makers (FDM) make informed donation decisions under stressful circumstances. The specific aims of the ELSI GTEx study are:
This study will build on this research team's extensive work in organ and tissue donation and the work they are currently conducting during the ELSI pilot of the GTEx project. Specifically, the investigators propose to examine the impact of stress and complex information on the decision making of donor families to inform the consent process, understand how variations in requesters, consent approaches, and the characteristics of family decision makers affect understanding and recall of and willingness to donate tissues for research, consider the ethical and legal issues of the request and consent process, and test an intervention to train tissue requesters to employ effective communication techniques when making requests for tissue. The overall goal is to develop a set of recommendations that will maximize the likelihood that family decision makers (FDM) make informed donation decisions under stressful circumstances. The specific aims of the ELSI GTEx study are:
Identify elements of nonverbal and relational communication impacting FDM knowledge, recall and GTEx decision making. Using the methods and procedures of the pilot study, the investigators will conduct an observational study of the GTEx request process to understand the communication-related variables impacting FDM knowledge, recall and decision making. In addition, a subsample of audiotapes will be obtained from tissue-only donors whose consent conversations are conducted by telephone and are audiotaped. This will provide information about the important nonverbal and relational elements of communication on the outcome variables.
H1a. Sociodemographic characteristics of FDM will impact the major outcomes of interest to this study (recall, comprehension and consent). Specifically, FDM who have more education, are white, female and younger will be more likely to donate, have better recall and knowledge.
H1b. Relational elements of communication, such as confirmational messages (e.g., messages that expressed validation or acceptance) or persuasive tactics such as credibility, altruism, or esteem, and engaging in a lengthier conversation will be associated with a greater likelihood to donate have better recall and knowledge.
H1c. Tissue requesters' and FDMs' comfort speaking about GTEx, the proclivity of FDMs to ask question and engage more proactively in the conversation will be associated with a greater likelihood to donate have better recall and knowledge.
- Conduct a study, using a quasi-experimental design, to understand the impact of the stressful environment in which the requests occur. This study will assist the ELSI team to obtain an evidence base that will allow us to disentangle the effects of stress from the complexity of the information about the purpose of the donation and guide recommendations for a final consent process.
- Adapt and test a communication intervention targeting tissue requesters' (TR) use of effective, ethically acceptable techniques that maximize the likelihood of consent.
H3a. Post intervention, TRs will exhibit more relational communication with FDMs during requests. H3b. Post intervention, TRs will spend more time attending to the emotional needs of FDMs.
H3c. Post intervention, TRs will spend more time discussing information identified as important to informed decision making for tissue donation.
H3d. Post intervention, there will be overall higher consent rates for donation to the research.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Virginia
-
Richmond, Virginia, United States, 23219
- Virginia Commonwealth University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Participants must either be a:
- family decision maker approached to donate their loved one's tissues to the GTEx project or
- a staff person at an OPO that approaches family decision makers for the GTEx project.
Exclusion Criteria:
1. Persons who neither approached for GTEx or were approached are excluded from participation.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention Group
Tissue requesters from participating OPOs are randomly assigned to complete additional informed consent training through an interactive online training website.
|
Additional training website can be found at gtextraing.org
|
Experimental: Control Group
The control group of tissue requesters receive the standard training offered by their OPO and GTEx partners.
|
Standard training given by OPOs and GTEx staff
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of family members who chose to donate to GTEx
Time Frame: Up to 8 months after donation request
|
Number of family decision makers who choose to donate to GTEx
|
Up to 8 months after donation request
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Knowledge and Comprehension of Elements of Consent
Time Frame: Up to 8 months after donation request
|
Knowledge and comprehension were assessed by participant answers to questionnaire.
|
Up to 8 months after donation request
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Laura Siminoff, PhD, Temple University
- Principal Investigator: Heather Traino, PhD, Temple University
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 10XS170
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Standard Training
-
Prisma Health-UpstateNational Institute on Drug Abuse (NIDA); Clemson UniversityRecruitingStandard of Care | Standard of Care + CBT4CBT | Standard of Care + CBT4CBT + RCUnited States
-
Nanfang Hospital of Southern Medical UniversityGuangzhou First People's Hospital; Second Affiliated Hospital, Sun Yat-Sen... and other collaboratorsUnknown
-
EMD SeronoMerck KGaA, Darmstadt, GermanyCompletedPatients With Solid Tumors, Either Refractory to Standard Therapy or for Which no Effective Standard Therapy is AvailableUnited States
-
Eagle Pharmaceuticals, Inc.CompletedCancer Which Has Either Progressed or Relapsed After Standard Therapy, or for Which no Curative or Standard Therapy is AppropriateUnited States
-
University of California, San FranciscoRecruitingPregnant Individuals Requesting Standard MicroarrayUnited States
-
Cook County HealthCompletedAdult Inpatients Referred for Standard EchocardiographyUnited States
-
Livzon Pharmaceutical Group Inc.Palm Beach CRO; Keystone Bioanalytical, Inc.CompletedSolid Tumor Refractory to Standard TherapyUnited States
-
University of MiamiCompletedStandard Yoga | Multi-directional Yoga | Educational ControlUnited States
-
University of HawaiiKlein Buendel, Inc.CompletedMomZing Exercise Videos Online | Standard Exercise DVDUnited States
-
KangLaiTe USACompletedNeoplasms | Solid Tumors Refractory To Standard TherapyUnited States
Clinical Trials on Training Website
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMalignant NeoplasmUnited States
-
NYU Langone HealthCompleted
-
Centre hospitalier de l'Université de Montréal...Canadian Institutes of Health Research (CIHR); CIHR Canadian HIV Trials NetworkCompleted
-
University of Illinois at ChicagoTerminatedHead and Neck CancerUnited States
-
University of Texas at AustinNot yet recruiting
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)RecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditionsUnited States
-
Odense University HospitalCompletedHealth Knowledge, Attitudes, Practice | Downs SyndromeDenmark
-
VA Office of Research and DevelopmentEnrolling by invitationHeart Failure | Cancer | Chronic Obstructive Pulmonary Disease | Dementia | Interstitial Lung Disease | End-stage Renal Disease | Seriously Ill Patients | End-stage Liver DiseaseUnited States
-
Northwestern UniversityPatient-Centered Outcomes Research InstituteCompletedAlzheimers, Falls, Aging in PlaceUnited States
-
University of MichiganEunice Kennedy Shriver National Institute of Child Health and Human Development...Not yet recruitingEndometriosis | Chronic Pelvic PainUnited States